The effects of population‐based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy

Adjuvant systemic therapy has been shown to be effective in reducing breast cancer mortality. The additional effect of mammography screening remains uncertain, in particular for women aged 40–49 years. We therefore assessed the effects of screening starting between age 40 and 50, as compared to the...

Ausführliche Beschreibung